SVLSF IV, LLC 4
4 · KalVista Pharmaceuticals, Inc. · Filed Mar 20, 2019
Insider Transaction Report
Form 4
SVLSF IV, LLC
10% Owner
Transactions
- Sale
Common Stock
2019-03-18$26.70/sh−255,224$6,814,481→ 1,936,352 total - Sale
Common Stock
2019-03-18$26.70/sh−7,246$193,468→ 54,973 total
Footnotes (3)
- [F1]These shares are held directly by SVLS IV LP.
- [F2]SVLS IV LP and Strategic Partners (each a "Fund", or collectively the "Funds") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliares. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP. may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC. disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein.
- [F3]These shares are held directly by Strategic Partners.